Cardiovascular Effects of Doxorubicin (Adriamycin®) and 4‐Demethoxydaunorubicin (Idarubicin®) in the Conscious Rat
- 1 January 1988
- journal article
- Published by Wiley in Basic & Clinical Pharmacology & Toxicology
- Vol. 62 (1) , 54-56
- https://doi.org/10.1111/j.1600-0773.1988.tb01844.x
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- New anthracycline analogs in advanced breast cancerEuropean Journal of Cancer and Clinical Oncology, 1986
- Relationship between Doxorubicin-Induced Ecg Changes and Myocardial Alterations in RatsTumori Journal, 1986
- The Effect of Vitamin E and Selenium on Doxorubicin (Adriamycin®) Induced Delayed Toxicity in MiceActa Pharmacologica et Toxicologica, 1986
- Activity of 4-demethoxydaunorubicin by the oral route in advanced breast cancerEuropean Journal of Cancer and Clinical Oncology, 1985
- Comparison of the severity of the chronic cardiotoxicity produced by doxorubicin in normotensive and hypertensive ratsToxicology and Applied Pharmacology, 1985
- Doxorubicin Cardiotoxicity in the RatJournal of Cardiovascular Pharmacology, 1984
- Antileukemic Activity of 4-Demethoxydaunorubicin in MiceTumori Journal, 1980
- Fluorescence assay of tissue distribution of 4-demethoxydaunorubicin and 4-demethoxydoxorubicin in mice bearing solid tumorsCancer Chemotherapy and Pharmacology, 1979
- Fine structural changes in rat myocardium induced by daunorubicinPathology, 1973
- A new method for determination of the systolic blood pressure in conscious ratsLife Sciences, 1970